Qube Research & Technologies (QRT)’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.75M | Buy |
457,112
+64,317
| +16% | +$528K | ﹤0.01% | 1374 |
|
2025
Q1 | $2.81M | Buy |
392,795
+38,802
| +11% | +$277K | ﹤0.01% | 1429 |
|
2024
Q4 | $2.74M | Buy |
353,993
+159,919
| +82% | +$1.24M | ﹤0.01% | 1385 |
|
2024
Q3 | $2.04M | Buy |
194,074
+84,092
| +76% | +$882K | ﹤0.01% | 1414 |
|
2024
Q2 | $1.29M | Buy |
109,982
+67,010
| +156% | +$784K | ﹤0.01% | 1518 |
|
2024
Q1 | $905K | Buy |
42,972
+24,034
| +127% | +$506K | ﹤0.01% | 1872 |
|
2023
Q4 | $340K | Buy |
+18,938
| New | +$340K | ﹤0.01% | 2170 |
|
2023
Q2 | – | Sell |
-43,491
| Closed | -$822K | – | 2817 |
|
2023
Q1 | $822K | Buy |
43,491
+6,436
| +17% | +$122K | ﹤0.01% | 1307 |
|
2022
Q4 | $840K | Buy |
+37,055
| New | +$840K | ﹤0.01% | 1226 |
|
2021
Q2 | – | Sell |
-15,045
| Closed | -$513K | – | 2713 |
|
2021
Q1 | $513K | Buy |
+15,045
| New | +$513K | 0.01% | 1160 |
|